etoposide has been researched along with Thromboembolism in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asbell, SO; Bae, K; Kerlin, KJ; Michalski, JM; Pienta, KJ; Rajan, R; Rosenthal, SA; Sandler, HM; Sobczak, ML | 1 |
| Musallam, KM; Taher, AT | 1 |
| Chin, C; Midulla, P; Shapiro, M; Wistinghausen, B | 1 |
| Douchi, T; Kamio, M; Matsuo, T; Terao, S; Tsuji, T; Yanazume, S | 1 |
| Ghosh, C; Jett, JR; Jung, SH; Kugler, JW; Kuross, SA; Loprinzi, CL; Mailliard, JA; Maksymiuk, AW; Owen, D; Rowland, KM; Schaefer, PL; Shaw, EG; Tschetter, LK; Washburn, JH; Webb, TA | 1 |
| Drach, J; Kaufmann, H; Nösslinger, T; Raderer, M; Urbauer, E | 1 |
3 trial(s) available for etoposide and Thromboembolism
| Article | Year |
|---|---|
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Estramustine; Etoposide; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Paclitaxel; Prostatic Neoplasms; Thromboembolism | 2009 |
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cachexia; Carcinoma, Small Cell; Cisplatin; Double-Blind Method; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Pain Measurement; Quality of Life; Survival Analysis; Survival Rate; Thromboembolism | 1996 |
Thromboembolic events during treatment with thalidomide.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Humans; Lymphoma, Mantle-Cell; Multiple Myeloma; Prednisone; Rituximab; Thalidomide; Thromboembolism; Vincristine | 2002 |
3 other study(ies) available for etoposide and Thromboembolism
| Article | Year |
|---|---|
Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Humans; Incidence; Lung Neoplasms; Randomized Controlled Trials as Topic; Small Cell Lung Carcinoma; Thalidomide; Thromboembolism | 2009 |
Metastatic osteosarcoma presenting as a single pulmonary microembolus.
Topics: Adolescent; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diagnosis, Differential; Diagnostic Errors; Enoxaparin; Etoposide; Femoral Neoplasms; Humans; Ifosfamide; Limb Salvage; Male; Neoplastic Cells, Circulating; Osteosarcoma; Pneumonectomy; Postoperative Complications; Pulmonary Artery; Pulmonary Embolism; Thromboembolism; Tomography, X-Ray Computed | 2011 |
Systemic thromboembolism after anti-cancer chemotherapy in a woman with ovarian germ cell tumor.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Infarction; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Thromboembolism | 2013 |